A multicenter randomized trial of paclitaxel (175 mg/m2) plus carboplatin (6AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6AUC) in advanced non-small cell lung cancer (NSCLC)
- 30 September 1999
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 35, S247
- https://doi.org/10.1016/s0959-8049(99)81398-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: